Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Jubilant HollisterStier Sterile Expansion Project Underway

Published: Friday, August 16, 2013
Last Updated: Friday, August 16, 2013
Bookmark and Share
New manufacturing area will expand ampoule manufacturing capacity in Montreal.

Jubilant HollisterStier has announced that the Montreal-based manufacturing facility has completed the first phase of an expansion of their sterile manufacturing capacity, with the addition of a new ampoule filling line utilizing a rigid barrier system.

This expansion of capacity is a continuation of improvements being made to further enhance the site’s sterile manufacturing capabilities.

The new manufacturing area will expand ampoule manufacturing capacity in Montreal by nearly two hundred percent.

In addition, expansions to the sterile areas at Jubilant HollisterStier have been optimized through successful implementation of Lean and Six Sigma initiatives.

The new area is scheduled to be ready for product on September 9th 2013. A significant portion of the expanded capacity has already been allocated to new customer products that will be manufactured at the site.

“We are excited to complete this phase of our optimization strategy in sterile manufacturing. Our site in Montreal will be well positioned to continue offering multiple dosage platforms for our global customers. We have been fortunate to secure several new contracts that will utilize our expanded capacity starting this year” said Jubilant HollisterStier Chief Executive Officer, Marcelo Morales.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

JHS Secures Multi-Million Dollar Contracts to Manufacture Sterile Parenteral Products
Company has secured contracts with four innovator life science companies.
Thursday, February 23, 2012
Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!